RIL
MRVI icon

Rothschild Investment LLC’s Maravai LifeSciences MRVI Stock Holding History

Rothschild Investment LLC’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.85K Sell
777
-1
-0.1% -$4 ﹤0.01% 2282
2026
Q1 		$2.2K Hold
778
– – ﹤0.01% 2514
2025
Q4 		$2.53K Buy
778
+8
+1% +$27 ﹤0.01% 2248
2025
Q3 		$2.21K Hold
770
– – ﹤0.01% 2168
2025
Q2 		$1.86K Buy
770
+615
+397% +$1.29K ﹤0.01% 2134
2025
Q1 		$343 Buy
155
+100
+182% +$395 ﹤0.01% 2734
2024
Q4 		$300 Sell
55
-65
-54% -$418 ﹤0.01% 2693
2024
Q3 		$997 Buy
120
+100
+500% +$864 ﹤0.01% 2171
2024
Q2 		$143 Buy
+20
New +$173 ﹤0.01% 2592

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Rothschild Investment LLC's MRVI Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Maravai LifeSciences (MRVI) stake by 0.13% in Q2 2026, selling an estimated $4 and leaving 777 shares worth $4.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2282.

Rothschild Investment LLC first reported a position in MRVI in Q2 2024 and has held it in 9 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Rothschild Investment LLC held 777 shares of Maravai LifeSciences worth $4.85K as of Q2 2026.
  • Rothschild Investment LLC sold 1 Maravai LifeSciences share in Q2 2026, an estimated $4.
  • Maravai LifeSciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2282 holding.
  • Rothschild Investment LLC first reported a position in Maravai LifeSciences in Q2 2024 and has held it in 9 quarters since.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.